| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |